alpha-reductase autoantibodies serum patients prostatic cancer Human sera ability alpha-reductase binding potent inhibitor enzyme Thirty serum samples patients prostatic cancer significant inhibitory activity serum samples patients inactive majority inhibitory activity IgG fraction chromatography protein A-Sepharose affinity column anti-human IgG-agarose column IgG fractions non-inhibitory sera inactive Inhibitory IgG enzymatic activity microsomal alpha-reductase liver ventral prostate preputial gland rat prostate facial skin human inhibitory IgG effect NADH-menadione reductase beta-hydroxysteroid dehydrogenase results alpha-reductase autoantibodies present blood prostatic cancer patients 